As Principal Scientist, Functional Genomics, you will combine cutting-edge biology, gene editing, and advanced screening approaches to uncover new therapeutic opportunities. You will develop and apply innovative, automation-friendly functional genomics capabilities, using automation and digital approaches to scale data generation and accelerate target identification and validation for progression to Novo’s research portfolio.
You are a scientifically accomplished and collaborative researcher with deep expertise in functional genomics and a proven ability to influence research strategy, technology development and scientific outcomes. You combine technical excellence with strong stakeholder engagement and leadership skills.
To succeed in this role, you will have:
Useful, but not essential:
As Principal Scientist in the Functional Genomics team, you will serve as a scientific leader, driving the development and implementation of advanced experimental approaches and the adoption of automation technologies and digital applications to scale data generation in support of TIM’s target discovery. You will work across multidisciplinary teams to establish innovative, automation-amenable in vitro assays, generate high-quality decision-making data, and help shape the future direction of functional genomics capabilities for screening within TIM. You will also mentor colleagues, influence scientific strategy, and build collaborations that enhance research impact.
Your responsibilities will include:
You will operate with a high degree of scientific independence and will be recognized as a subject matter expert, contributing to both strategic and operational decisions that enable the progression of novel therapeutic targets into the research pipeline.
The Target Identification and Maturation (TIM) department, based at Novo Nordisk Research and Development UK (NNRDUK) in Oxford, is part of Novo Nordisk Global Research. TIM plays a pivotal role in discovering, validating, and advancing novel therapeutic targets that address unmet patient needs across Novo Nordisk’s research portfolio. Leveraging cutting-edge human biology, advanced experimental platforms, computational approaches, and translational science, the department generates insights that enable target identification, mechanistic understanding, and target maturation towards project initiation.
Our multidisciplinary teams work across the target discovery value chain, integrating in vitro and in silico capabilities, functional genomics, screening technologies, data science, and disease biology to uncover and de-risk new therapeutic opportunities. While maintaining a strong focus on cardiometabolic diseases, including obesity, type 2 diabetes, chronic kidney disease, cardiovascular disease, and related co-morbidities, TIM also supports the exploration of emerging therapeutic areas and novel biological pathways.
The Oxford research centre thrives on collaboration. We maintain strong partnerships with leading academic institutions, particularly the University of Oxford, as well as biotechnology and technology partners worldwide. As part of a global research organization, TIM works closely with colleagues in Denmark, Boston, and across Novo Nordisk Global Research to translate scientific discoveries into the next generation of innovative medicines for patients.
You will join a scientific community where curiosity and patient focus are central to how we work, and where your expertise can help shape important decisions. You will be trusted to take ownership and make your voice heard, while being supported to grow through mentorship, collaboration, and challenging work across therapeutic areas and development stages.
We are an equal opportunities employer, and we are committed to an inclusive recruitment process and equality of opportunity for all our applicants. If you are a person with a disability, or if you are neurodivergent and require adjustments during the application or selection process, please email AZZQ@novonordisk.com. Please include your name, the role you are interested in, and the type of adjustment you need, so we can support you throughout the process.
Your impact begins today. If you are ready to turn complex safety data into insights that protect patients and guide development decisions, apply for the role by 11 October 2026. Applications are reviewed on an ongoing basis, so we encourage you to apply as soon as possible.
We commit to an inclusive recruitment process and equality of opportunity for all our job applicants.

We’re not your typical healthcare company. In a modern world of quick fixes, we focus on solutions to defeat serious chronic disease and create long-term health.
Our unordinary mindset is at the heart of everything we do. We seek out new ideas and put people first as we push the boundaries of science, make healthcare more accessible, and work to treat, prevent, and even cure diseases that affect millions of lives. Founded in Denmark in 1923, today we employ more than 77,000 people in 80 offices around the world – all united by our bold purpose to drive change to defeat serious chronic diseases. Want to learn more? Visit www.novonordisk.com.
This page isn’t intended for discussions about products. As such, postings or comments that contain product discussions may be removed. This page is for discussions about Novo Nordisk and its subsidiaries and the initiatives and projects we are involved in. While we welcome everyone to make comments, we reserve the right to remove those that are off-topic, abusive or intended to spam.
Any questions specific to products should be made to your healthcare professional. If you wish to file an adverse drug reaction please contact Novo Nordisk’s office in the country you live in:
https://www.novonordisk.com/contact-us/find-local-information.html
For other customer complaints, please contact us here:
https://www.novonordisk.com/contact-us.html
Please keep in mind that Novo Nordisk A/S and its subsidiaries work within a highly regulated industry. Therefore, comments that pertain to legal matters or regulatory issues may be removed.
Comments contained on this site come from members of the public, and do not necessarily reflect the views of Novo Nordisk A/S. Novo Nordisk A/S does not endorse or approve any content added by other LinkedIn users.
Learn more about our privacy disclaimer and community guidelines here: https://www.novonordisk.com/data-privacy-and-user-rights/social-media-privacy-disclaimer.html